psoriasis

Guselkumab front and center at EADV Congress
Guselkumab front and center at EADV CongressIL-23 inhibitors represent one more very effective strategy for controlling psoriasis with PASI rates comparable to other biologics.
New guidelines: Screening for pediatric psoriasis comorbiditiesRecommendations emphasize early detection of risks for medical comorbidities later in life.
Psoriasis and atopic dermatitis respond to IL-17 creamNitric oxide-releasing cream that targets IL-17 moving toward clinical trials.
New psoriasis patient profileMetabolomics could provide new statistical methods to help monitor psoriasis disease and progression.
Biologic risk tolerance differs for pregnant patientsOf several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, not all have the same safety profile during pregnancy and lactation periods.
Expense drivers for costliest psoriasis patientsFindings of a recent study challenge the notion that psoriasis patients may be generally healthy and only occur expenses related to their medications or psoriasis.
Dermatologists collaborate on data-driven pediatric psoriasis researchA global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes
Sulzberger lecturer provides in-depth look at psoriasis comorbiditiesIn his talk at AAD 2017, Joel M. Gelfand, MD, MSCE, discussed the findings from research investigating associations between psoriasis and comorbidities and their relevance for providing comprehensive medical care for patients with psoriasis.
How psoriasis arisesThe research road to streamlining the model of psoriasis pathogenesis.
Psoriasis treatment in skin of color
Psoriasis treatment in skin of colorWhen it comes to treating psoriasis in non-white patients, there is a paucity of data on differences in epidemiology, clinical presentation and approaches to treatment.